Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells-Reference-Cited by-同舟云学术

Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells

Published:1998-05 Issue:6 Volume:34 Page:902-907
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mehta R.R.,Hawthorne M.E.,Graves J.M.,Mehta R.G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Chemoprevention of cancer by retinoids;Sporn;Fed Proc,1979

2. Schiff LJ, Okamura WH, Dawson MI, Hobbs PD. Structure–biological relationship of new synthetic retinoid on epithelial differentiation of cultured hamster tracheas. In Dawson MI, Okamura WH, eds. Chemistry and Biology of Synthetic Retinoids. Boca Raton, FL, CRC Press, 1989, 307–363.

3. Moon RC, Thompson HJ, Becci PJ, et al. N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 1979, 39, 1339–1346.

4. Moon RC, Mehta RG, Rao KVN. Retinoids and cancer in experimental animals. In Sporn MB, Roberts AB, Goodman DS, eds. Retinoids: Biology, Chemistry and Medicine. New York, Academic Press, 1994, 573–593.

5. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor;Moon;Carcinogenesis,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenretinide inhibits vitamin A formation from β-carotene and regulates carotenoid levels in mice;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2022-02

2. Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia;Anti-Cancer Drugs;2019-02

3. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1;PLOS ONE;2017-04-27

4. Analysis of fenretinide and its metabolites in human plasma by liquid chromatography–tandem mass spectrometry and its application to clinical pharmacokinetics;Journal of Pharmaceutical and Biomedical Analysis;2017-01

5. Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure;British Journal of Pharmacology;2011-06-27